|
21.
|
|
16 p, 4.6 MB |
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease
/
Moore, Ursula (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Gordish-Dressman, Heather (George Washington University) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
James, Meredith K. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Mayhew, Anna G. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Guglieri, Michela (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Fernandez-Torron, Roberto (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Rufibach, Laura E. (The Jain Foundation) ;
Feng, Jia (Center for Translational Science. Division of Biostatistics and Study Methodology. Children's National Health System) ;
Blamire, Andrew (Magnetic Resonance Centre. Translational and Clinical Research Institute. Newcastle University) ;
Carlier, Pierre G. (AIM & CEA NMR Laboratory. Institute of Myology. Pitié-Salpêtrière University Hospital) ;
Spuler, Simone (Charite Muscle Research Unit. Experimental and Clinical Research Center. a Joint Cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Day, John W (Stanford University School of Medicine) ;
Jones, Kristi J. (The Children's Hospital at Westmead. and The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, Emmanuelle (Service des maladies neuromusculaire et de la SLA. Hôpital de La Timone) ;
Pestronk, Alan (Washington University School of Medicine) ;
Walter, Maggie C. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians-University of Munich) ;
Paradas, Carmen (Instituto de Biomedicina de Sevilla) ;
Stojkovic, Tanya (Sorbonne Université) ;
Mori-Yoshimura, Madoka (Department of Neurology. National Center Hospital. National Center of Neurology and Psychiatry) ;
Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Pegoraro, Elena (University of Padova) ;
Lowes, Linda P (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Mendell, Jerry R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Bushby, Kate (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust) ;
Straub, Volker (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust)
This study aims to determine clinically relevant phenotypic differences between the two most common phenotypic classifications in dysferlinopathy, limb girdle muscular dystrophy R2 (LGMDR2) and Miyoshi myopathy (MMD1). [...]
2021 -  10.1016/j.nmd.2021.01.009
Neuromuscular Disorders, Vol. 31 Núm. 4 (april 2021) , p. 265-280
|
|
|
22.
|
|
12 p, 2.7 MB |
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale
/
Jacobs, M.B. (Pediatrics. Epidemiology. and Biostatistics. George Washington University) ;
James, Meredith K (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Lowes, Linda P (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Alfano, Lindsay N (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Eagle, M. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Muni Lofra, R. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Moore, U. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Feng, J. (Center for Translational Science. Division of Biostatistics and Study Methodology. Children's National Health System) ;
Rufibach, L.E. (The Jain Foundation) ;
Rose, K. (The Children's Hospital at Westmead. The University of Sydney) ;
Duong, T. (Lucile Salter Packard Children's Hospital at Stanford) ;
Bello, Luca (Department of Neuroscience. University of Padova) ;
Pedrosa-Hernández, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Holsten, Scott (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Sakamoto, C. (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry) ;
Canal, Aurélie (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ;
Sanchez-Aguilera Práxedes, N. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Thiele, S. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians University of Munich) ;
Siener, C. (Department of Neurology Washington University School of Medicine) ;
Vandevelde, B. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ;
DeWolf, Brittney (Cooperative International Neuromuscular Research Group (CINRG). Children's National Health System) ;
Maron, E. (ELAN-PHYSIO. Praxis für Physiotherapie Maron) ;
Guglieri, M. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Hogrel, J.Y. (Institut de Myologie (París, França)) ;
Blamire, Andrew (Magnetic Resonance Centre. Institute for Cellular Medicine. Newcastle University) ;
Carlier, Pierre G (AIM & CEA NMR Laboratory. Institute of Myology. Pitié-Salpêtrière University Hospital) ;
Spuler, S. (Charite Muscle Research Unit. Experimental and Clinical Research Center. a joint cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ;
Day, John W (Department of Neurology and Neurological Sciences. Stanford University School of Medicine) ;
Jones, K.J. (The Children's Hospital at Westmead. The University of Sydney) ;
Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ;
Salort-Campana, E. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ;
Pestronk, Alan (Washington University School of Medicine) ;
Walter, Maggie C (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians University of Munich) ;
Paradas, C. (Instituto de Biomedicina de Sevilla) ;
Stojkovic, T. (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ;
Mori-Yoshimura, Madoka (National Center of Neurology and Psychiatry Tokyo) ;
Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Pegoraro, Elena (University of Padova) ;
Mendell, J. R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ;
Mayhew, A.G. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ;
Straub, Volker (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway)
Objective: Dysferlinopathy is a muscular dystrophy with a highly variable clinical presentation and currently unpredictable progression. This variability and unpredictability presents difficulties for prognostication and clinical trial design. [...]
2021 - 10.1002/ana.26044
Annals of neurology, Vol. 89 Núm. 5 (may 2021) , p. 967-978
|
|
|
23.
|
|
11 p, 1.0 MB |
STIG study : real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa
/
Gutschmidt, K. (Department of Neurology. Friedrich-Baur-Institute. Ludwig-Maximilians University Munich) ;
Musumeci, O. (Department of Clinical and Experimental Medicine. University of Messina) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Chien, Y.H. (Department of Medical Genetics and Pediatrics. National Taiwan University Hospital) ;
Knop, K.C. (Neurologische Praxis Neuer Wall) ;
Wenninger, S. (Department of Neurology. Friedrich-Baur-Institute. Ludwig-Maximilians University Munich) ;
Montagnese, F. (Department of Neurology. Friedrich-Baur-Institute. Ludwig-Maximilians University Munich) ;
Pugliese, A. (Department of Clinical and Experimental Medicine. University of Messina) ;
Tavilla, G. (Department of Clinical and Experimental Medicine. University of Messina) ;
Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Hwu, P.W.L. (Department of Medical Genetics and Pediatrics. National Taiwan University Hospital) ;
Toscano, A. (Department of Clinical and Experimental Medicine. University of Messina) ;
Schoser, B. (Department of Neurology. Friedrich-Baur-Institute. Ludwig-Maximilians University Munich)
Background: Pompe disease is one of the few neuromuscular diseases with an approved drug therapy, which has been available since 2006. Our study aimed to determine the real-world long-term efficacy and safety of alglucosidase alfa. [...]
2021 - 10.1007/s00415-021-10409-9
Journal of Neurology, Vol. 268 Núm. 7 (july 2021) , p. 2482-2492
|
|
|
24.
|
|
15 p, 2.2 MB |
Muscle MRI in immune-mediated necrotizing myopathy (IMNM) : implications for clinical management and treatment strategies
/
Fionda, Laura (Università degli Studi di Roma La Sapienza) ;
Lauletta, Antonio (Università degli Studi di Roma La Sapienza) ;
Leonardi, Luca (Università degli Studi di Roma La Sapienza) ;
Perez, Jorge Alonso (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Morino, Stefania (Università degli Studi di Roma La Sapienza) ;
Merlonghi, Gioia (Università degli Studi di Roma La Sapienza) ;
Alfieri, Girolamo (Università degli Studi di Roma La Sapienza) ;
Costanzo, Rocco (Università degli Studi di Roma La Sapienza) ;
Tufano, Laura (Università degli Studi di Roma La Sapienza) ;
Vanoli, Fiammetta (IRCCS Istituto Neurologico Carlo Besta) ;
Rossini, Elena (Università degli Studi di Roma La Sapienza) ;
Vigo, Eduard Gallardo (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Tartaglione, Tommaso (Istituto Dermopatico dell'Immacolata (Itàlia)) ;
Salvetti, Marco (Università degli Studi di Roma La Sapienza) ;
Antonini, Giovanni (Università degli Studi di Roma La Sapienza) ;
Diaz-Manera, Jordi (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Garibaldi, Matteo (Università degli Studi di Roma La Sapienza) ;
Universitat Autònoma de Barcelona
Immune-mediated necrotizing myopathy (IMNM) is the most severe idiopathic inflammatory myopathy (IIM) and early aggressive poly-immunotherapy is often required to reduce long-term disability. The aim of this study is to investigate muscle MRI in IMNM as outcome measure for disease activity, severity, progression, response to treatment, and to better characterize the pattern of muscle involvement. [...]
2022 - 10.1007/s00415-022-11447-7
Journal of Neurology, Vol. 270 (november 2022) , p. 960-974
|
|
|
25.
|
|
11 p, 757.3 KB |
Charcot-Marie-Tooth disease due to MORC2 mutations in Spain
/
Sivera, Rafael (Hospital Francesc de Borja) ;
Lupo, Vincenzo (Unit of Rare Neurodegenerative Diseases Felipe. Centro de Investigación Príncipe) ;
Frasquet, Marina (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Argente-Escrig, Herminia (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
del Mar García-Romero, Maria (Universidad Autónoma de Madrid. Departamento de Pediatría) ;
Ignacio Pascual, Samuel (Universidad Autónoma de Madrid. Departamento de Pediatría) ;
García-Sobrino, Tania (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Paradas, Carmen (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Francisco Vázquez-Costa, Juan (Universitat de València. Departament de Medicina) ;
Muelas, Nuria (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Millet, Elvira (Hospital Universitari i Politècnic La Fe (València)) ;
Vílchez, Juan Jesús (Universitat de València. Departament de Medicina) ;
Espinós, Carmen (Unit of Rare Neurodegenerative Diseases Felipe. Centro de Investigación Príncipe) ;
Sevilla, T. (Universitat de València. Departament de Medicina) ;
Universitat Autònoma de Barcelona
IIB.
Background and purpose: MORC2 mutations have been described as a rare cause of axonal Charcot-Marie-Tooth disease (CMT2Z). The aim of this work was to determine the frequency and distribution of these mutations throughout Spain, to provide a comprehensive phenotypical description and, if possible, to establish a genotype-phenotype correlation. [...]
2021 - 10.1111/ene.15001
European Journal of Neurology, Vol. 28 Núm. 9 (september 2021) , p. 3001-3011
|
|
|
26.
|
|
9 p, 2.1 MB |
Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests
/
Nuñez Peralta, Claudia Alejandra (Institut d'Investigació Biomèdica Sant Pau) ;
Montesinos, P. (Philips Healthcare Iberia) ;
Alonso-Jiménez, Alicia (University Hospital Antwerp (Bèlgica)) ;
Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Reyes-Leiva, David (Institut d'Investigació Biomèdica Sant Pau) ;
Sánchez-González, J. (Philips Healthcare Iberia) ;
Llauger, Jaume (Institut d'Investigació Biomèdica Sant Pau) ;
Segovia, Sonia (Institut d'Investigació Biomèdica Sant Pau) ;
Belmonte Jimeno, Izaskun (Institut d'Investigació Biomèdica Sant Pau) ;
Pedrosa, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Martínez-Noguera, A. (Institut d'Investigació Biomèdica Sant Pau) ;
Matellini-Mosca, B. (Institut d'Investigació Biomèdica Sant Pau) ;
Walter, G. (Department of Physiology and Functional Genomics. University of Florida) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau)
Objectives: Magnetization transfer (MT) imaging exploits the interaction between bulk water protons and protons contained in macromolecules to induce signal changes through a special radiofrequency pulse. [...]
2021 - 10.3389/fneur.2021.634766
Frontiers in neurology, Vol. 12 (march 2021) , p. 634766
|
|
|
27.
|
|
8 p, 1.1 MB |
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease
/
Alonso-Jiménez, Alicia (University Hospital Antwerp (Bèlgica)) ;
Nuñez Peralta, Claudia Alejandra (Universitat Autònoma de Barcelona) ;
Montesinos, P. (Philips Healthcare Iberia) ;
Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
García-Sánchez, Carmen (Institut d'Investigació Biomèdica Sant Pau) ;
Montiel, E. (Universitat Autònoma de Barcelona) ;
Belmonte Jimeno, Izaskun (Institut d'Investigació Biomèdica Sant Pau) ;
Pedrosa, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Segovia, Sonia (Institut d'Investigació Biomèdica Sant Pau) ;
Llauger, Jaume (Institut d'Investigació Biomèdica Sant Pau) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Quantitative MRI is an increasingly used method to monitor disease progression in muscular disorders due to its ability to measure changes in muscle fat content (reported as fat fraction) over a short period. [...]
2021 - 10.3389/fneur.2021.675781
Frontiers in neurology, Vol. 12 (august 2021) , p. 675781
|
|
|
28.
|
|
11 p, 1.1 MB |
Isolation of human fibroadipogenic progenitors and satellite cells from frozen muscle biopsies
/
Suárez-Calvet, X. (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Fernández-Simón, E. (University of Newcastle) ;
Piñol-Jurado, Patricia (University of Newcastle) ;
Alonso-Pérez, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Carrasco-Rozas, Ana (Institut d'Investigació Biomèdica Sant Pau) ;
Lleixà, Cinta (Institut d'Investigació Biomèdica Sant Pau) ;
López-Fernández, Susana (Institut d'Investigació Biomèdica Sant Pau) ;
Pons, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Soria, L. (Universitat Autònoma de Barcelona) ;
Bigot, Anne (Sorbonne Université) ;
Mouly, V. (Sorbonne Université) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Gallardo, Eduard (Institut d'Investigació Biomèdica Sant Pau) ;
Jaiswal, J. K. (Department of Genomics and Precision Medicine. George Washington University School of Medicine and Health Sciences. and Center for Genetic Medicine Research. Children's National Hospital) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau)
Skeletal muscle contains multiple cell types that work together to maintain tissue homeostasis. Among these, satellite cells (SC) and fibroadipogenic progenitors cells (FAPs) are the two main stem cell pools. [...]
2021 - 10.1096/fj.202100588R
FASEB Journal, Vol. 35 Núm. 9 (september 2021) , p. e21819
|
|
|
29.
|
|
17 p, 2.7 MB |
Nintedanib Reduces Muscle Fibrosis and Improves Muscle Function of the Alpha-Sarcoglycan-Deficient Mice
/
Alonso-Pérez, Jorge (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Carrasco-Rozas, Ana (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Borrell-Pages, Maria (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Fernández Simón, Esther (Newcastle University) ;
Piñol-Jurado, Patricia (Newcastle University) ;
Badimon, Lina (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Wollin, Lutz (Boehringer Ingelheim) ;
Lleixà, Cinta (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Gallardo, Eduard (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Olive, Montse (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Diaz-Manera, Jordi (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Suárez-Calvet, Xavier (Centro de Investigación Biomédica en Red de Enfermedades Raras)
Sarcoglycanopathies are a group of recessive limb-girdle muscular dystrophies, characterized by progressive muscle weakness. Sarcoglycan deficiency produces instability of the sarcolemma during muscle contraction, leading to continuous muscle fiber injury eventually producing fiber loss and replacement by fibro-adipose tissue. [...]
2022 - 10.3390/biomedicines10102629
Biomedicines, Vol. 10 Núm. 10 (october 2022) , p. 2629
|
|
|
30.
|
|
13 p, 1.9 MB |
Autoantibody screening in Guillain-Barré syndrome
/
Lleixà, Cinta (Institut d'Investigació Biomèdica Sant Pau) ;
Martín-Aguilar, Lorena (Institut d'Investigació Biomèdica Sant Pau) ;
Pascual-Goñi, Elba (Institut d'Investigació Biomèdica Sant Pau) ;
Franco-Leyva, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Caballero-Ávila, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
de Luna Salva, Noemí (Institut d'Investigació Biomèdica Sant Pau) ;
Gallardo, Eduard (Institut d'Investigació Biomèdica Sant Pau) ;
Suarez-Calvet, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Martínez-Martínez, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Rojas-Garcia, Ricard (Institut d'Investigació Biomèdica Sant Pau) ;
Cortés-Vicente, Elena (Institut d'Investigació Biomèdica Sant Pau) ;
Turón, Joana (Institut d'Investigació Biomèdica Sant Pau) ;
Casasnovas, Carlos (Institut d'Investigació Biomèdica de Bellvitge) ;
Homedes, C. (Hospital Universitari de Bellvitge) ;
Gutiérrez-Gutiérrez, Gerardo (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
Jimeno-Montero, M. C. (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
Berciano, José (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Sedano-Tous, M. J. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
García-Sobrino, Tania (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Pardo, Julio (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Márquez-Infante, C. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Rojas-Marcos, I. (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Jericó, Ivonne (Complejo Hospitalario de Navarra) ;
Martínez-Hernández, E. (Hospital Clínic i Provincial de Barcelona) ;
Morís, Germán (Hospital Universitario Central de Asturias) ;
Domínguez-González, C. (Hospital Universitario 12 de Octubre (Madrid)) ;
Juarez, Candido (Institut d'Investigació Biomèdica Sant Pau) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Background: Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous presentation. Although some evidences support the role of autoantibodies in its pathogenesis, the target antigens remain unknown in a substantial proportion of GBS patients. [...]
2021 - 10.1186/s12974-021-02301-0
Journal of neuroinflammation, Vol. 18 Núm. 1 (december 2021) , p. 251
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
